Glycopyrrolate/Formoterol Fumarate MDI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glycopyrrolate/Formoterol Fumarate MDI, covering 2016-06-30 to 2016-06-30. Get the full timeline:
Most recent: Clinical Trial Update: Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]